Extended Data Figure 2 : Development of anti-MAb immune responses in recipients of anti-HIV-1 bNAbs.

From: A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges

Extended Data Figure 2

ad, Longitudinal analysis of anti-VRC01, anti-3BNC117, anti-10-1074, and anti-VRC01-LS antibody responses, respectively, after a single intravenous infusion of indicated MAbs. This assay was performed twice.